Invasive Staphylococcus aureus infections associated with pain injections and reuse of single-dose vials - Arizona and Delaware, 2012

Morbidity and Mortality Weekly Report

Volumn 61, Issue 27, 2012, Pages 501-504

  Anderson, Shoana ^a   Rigler, Jessica ^a   Oberoi, Vinita ^a   Christ, Cara ^a   Eggers, Paula ^b   Lempp, Jason ^c   Schaefer, Melissa ^d   Guh, Alice ^d   O'Connell, Heather ^d   Albrecht, Valerie ^d   Perz, Joseph ^d  

^a Arizona Dept of Health Svcs   (United States)

^b Delaware Div of Public Health   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CONTRAST MEDIUM;

ARTICLE; DEBRIDEMENT; DISEASE TRANSMISSION; EPIDEMIC; EQUIPMENT; HUMAN; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PAIN; RECYCLING; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ANALGESICS; ARIZONA; CONTRAST MEDIA; DEBRIDEMENT; DELAWARE; DISEASE OUTBREAKS; EQUIPMENT CONTAMINATION; EQUIPMENT REUSE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PAIN; STAPHYLOCOCCAL INFECTIONS;

EID: 84865024558     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. CDC. Injection safety. CDC's position-protect patients against preventable harm from improper use of single-dose/single-use vials. Atlanta, GA: US Department of Health and Human Services, CDC; 2012. Available at http://www.cdc.gov/injectionsafety/cdcposition-singleusevial.html. Accessed July 6, 2012.
2. CDC. Injection safety. CDC's clinical reminder: spinal injection procedures performed without a facemask pose risk for bacterial meningitis. Atlanta, GA: US Department of Health and Human Services, CDC; 2011. Available at http://www.cdc.gov/injectionsafety/spinalinjection-meningitis.html. Accessed July 6, 2012.
3. CDC. Healthcare-associated infections (HAIs). Guide to infection prevention for outpatient settings: minimum expectations for safe care. Atlanta, GA: US Department of Health and Human Services, CDC; 2011. Available at http://www.cdc.gov/hai/settings/outpatient/outpatient-care-guidelines.html. Accessed July 6, 2012.
4. Division of Public Health, Delaware Department of Health and Social Services. Delaware Health Alert Network no. 267. Health advisory. Infection prevention in outpatient settings: safe injection practices. Dover, DE: Delaware Department of Health and Social Services, Division of Public Health; 2012. Available at http://dhss.delaware.gov/dph/php/alerts/dhan267.html. Accessed July 6, 2012.
5. CDC. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Atlanta, GA: US Department of Health and Human Services, CDC; 2007. Available at http://www.cdc.gov/hicpac/2007ip/2007isolationprecautions.html. Accessed July 6, 2012.
6. Frost BA, Kainer MA. Safe preparation and administration of intravitreal bevacizumab injections. New Engl J Med 2011;365:2238.
7. CDC. Notes from the field: Multistate outbreak of postprocedural fungal endophthalmitis associated with a single compounding pharmacy-United States, March-April 2012. MMWR 2012;61:310-1.